Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 14

1.

Selinexor-based regimens for the treatment of myeloma refractory to chimeric antigen receptor T cell therapy.

Chari A, Vogl DT, Jagannath S, Jasielec J, Unger TJ, DeCastro A, Shah J, Kauffman M, Shacham S, Jakubowiak A.

Br J Haematol. 2020 Mar 2. doi: 10.1111/bjh.16550. [Epub ahead of print] No abstract available.

PMID:
32124443
2.

Results from a multidisciplinary clinic guided by geriatric assessment before stem cell transplantation in older adults.

Derman BA, Kordas K, Ridgeway J, Chow S, Dale W, Lee SM, Aguada E, Jakubowiak AJ, Jasielec J, Kline J, Kosuri S, Larson RA, Liu H, Mortel M, Odenike O, Pisano J, Riedell P, Stock W, Bishop MR, Artz AS.

Blood Adv. 2019 Nov 26;3(22):3488-3498. doi: 10.1182/bloodadvances.2019000790.

3.

Phase 1 study of selinexor plus carfilzomib and dexamethasone for the treatment of relapsed/refractory multiple myeloma.

Jakubowiak AJ, Jasielec JK, Rosenbaum CA, Cole CE, Chari A, Mikhael J, Nam J, McIver A, Severson E, Stephens LA, Tinari K, Rosebeck S, Zimmerman TM, Hycner T, Turowski A, Karrison T, Zonder JA.

Br J Haematol. 2019 Aug;186(4):549-560. doi: 10.1111/bjh.15969. Epub 2019 May 24.

4.

Sensitivity and Selectivity of Ion-Selective Electrodes Interpreted Using the Nernst-Planck-Poisson Model.

Jasielec JJ, Mousavi Z, Granholm K, Sokalski T, Lewenstam A.

Anal Chem. 2018 Aug 7;90(15):9644-9649. doi: 10.1021/acs.analchem.8b02659. Epub 2018 Jul 11.

PMID:
29932635
5.

Ofatumumab monotherapy in relapsed/refractory diffuse large B-cell non-Hodgkin lymphoma.

Galanina N, Jasielec J, Peace D, Smith SM, Nabhan C.

Leuk Lymphoma. 2017 Mar;58(3):752-753. doi: 10.1080/10428194.2016.1207764. Epub 2016 Jul 14. No abstract available.

PMID:
27415580
6.

Synergistic Myeloma Cell Death via Novel Intracellular Activation of Caspase-10-Dependent Apoptosis by Carfilzomib and Selinexor.

Rosebeck S, Alonge MM, Kandarpa M, Mayampurath A, Volchenboum SL, Jasielec J, Dytfeld D, Maxwell SP, Kraftson SJ, McCauley D, Shacham S, Kauffman M, Jakubowiak AJ.

Mol Cancer Ther. 2016 Jan;15(1):60-71. doi: 10.1158/1535-7163.MCT-15-0488. Epub 2015 Dec 4.

7.

Neutral-carrier ion-selective electrodes assessed by the Nernst-Planck-Poisson model.

Jasielec JJ, Sokalski T, Filipek R, Lewenstam A.

Anal Chem. 2015 Sep 1;87(17):8665-72. doi: 10.1021/acs.analchem.5b00065. Epub 2015 Aug 18.

PMID:
26241734
8.

Proteomic profiling of naïve multiple myeloma patient plasma cells identifies pathways associated with favourable response to bortezomib-based treatment regimens.

Dytfeld D, Rosebeck S, Kandarpa M, Mayampurath A, Mellacheruvu D, Alonge MM, Ngoka L, Jasielec J, Richardson PG, Volchenboum S, Nesvizhskii AI, Sreekumar A, Jakubowiak AJ.

Br J Haematol. 2015 Jul;170(1):66-79. doi: 10.1111/bjh.13394. Epub 2015 Mar 30.

9.

Carfilzomib, lenalidomide, and low-dose dexamethasone in elderly patients with newly diagnosed multiple myeloma.

Dytfeld D, Jasielec J, Griffith KA, Lebovic D, Vesole DH, Jagannath S, Al-Zoubi A, Anderson T, Detweiler-Short K, Stockerl-Goldstein K, Ahmed A, Jobkar T, Durecki DE, McDonnell K, Mietzel M, Couriel D, Kaminski M, Vij R, Jakubowiak AJ.

Haematologica. 2014 Sep;99(9):e162-4. doi: 10.3324/haematol.2014.110395. Epub 2014 Jun 27. No abstract available.

10.

Dasatinib-Related Pulmonary Toxicity Mimicking an Atypical Infection.

Jasielec JK, Larson RA.

J Clin Oncol. 2016 Feb 20;34(6):e46-8. doi: 10.1200/JCO.2013.50.1981. Epub 2014 Jun 23. No abstract available.

PMID:
24958829
11.

The mechanistic role of DNA methylation in myeloid leukemogenesis.

Jasielec J, Saloura V, Godley LA.

Leukemia. 2014 Sep;28(9):1765-73. doi: 10.1038/leu.2014.163. Epub 2014 May 20. Review.

PMID:
24913729
12.

Current approaches to the initial treatment of symptomatic multiple myeloma.

Jasielec JK, Jakubowiak AJ.

Int J Hematol Oncol. 2013 Feb;2(1). doi: 10.2217/ijh.13.3.

13.

Evolving strategies in the initial treatment of multiple myeloma.

Rosenbaum C, Jasielec J, Laubach J, Paba Prada C, Richardson P, Jakubowiak AJ.

Semin Oncol. 2013 Oct;40(5):592-601. doi: 10.1053/j.seminoncol.2013.08.002. Review.

PMID:
24135404
14.

Initiation of aspirin therapy modulates angiogenic protein levels in women with breast cancer receiving tamoxifen therapy.

Holmes CE, Jasielec J, Levis JE, Skelly J, Muss HB.

Clin Transl Sci. 2013 Oct;6(5):386-90. doi: 10.1111/cts.12070. Epub 2013 May 15.

Supplemental Content

Loading ...
Support Center